CD11a

SKU: P11AF1-100T Categories: ,

212,67 € – 553,57 € VAT excl.

This antibody reacts with the CD11a- antigen, located on the alpha-L chain of LFA-1 complex (Lymphocyte Function-associated Antigen-1), which is expressed on mature immunocompetent lymphocytes and their neoplastic counterparts, granulocytes and monocytes.

Additional information

Conjugated

, , , ,

Size

,

Regulatory Status

,

Clone

Gene ID

Format

Species Reactivity

Isotype

Tested Applications

Clonality

UniProt

Mw

Storage Store in the dark at 2-8°C.
Other names

Integrin alpha-L, CD11 antigen-like family member A, Leukocyte adhesion glycoprotein LFA-1 alpha chain, LFA-1A, Leukocyte function-associated molecule 1 alpha chain.
Buffer

The reagent is provided in aqueous buffered solution containing protein stabilizer, and ≤0.09% sodium Azide (NaN3).
Immunogen

PMA and Ionomycin activated T cells blast (Human).
Concentration

Please refer to the Certificate of Analysis for the lot-specific concentration. Typically 0,05 mg/ml.

Recomended usage

CD11a, clone TP1/40, is a mAb intended for identification/enumeration of human leucocytes using FCM. This reagent is effective for direct IF staining of human tissue for FCM analysis using ≤1 μg/10^6 cells.

Resources

Technical Data Sheet (TDS) (CE-IVD) – (English)

Hoja Técnica (TDS) (CE-IVD) – (Español)

Technical Data Sheet (TDS) (RUO) – (English)

Safety Sheet (MSDS) (CE-IVD) – (English)

Ficha de Seguridad (MSDS) (CE-IVD) – (Español)

Safety Sheet (MSDS) (RUO) – (English)

Instruction for Use (IFU) (CE-IVD) – (German)

Instruction for Use (IFU) (CE-IVD) – (Italian)

Instruction for Use (IFU) (CE-IVD) – (Portuguese)

Instruction for Use (IFU) (CE-IVD) – (French)

References

Product descriptionReferenceTitleAuthorsJournalYear
Product descriptionReferenceTitleAuthorsJournalYear

Related products

logo_footer

Follow us on our networks and stay informed.

LOCATION:

Centro Investigación del Cáncer (C.I.C) Avda. Universidad de Coimbra, s/n Campus Miguel de Unamuno 37007 Salamanca

+34 923 294 827 

info@immunostep.com

NextGenEU
Plan de Recuperación, Transformación y Resiliencia

© 2024 Immunostep